HAUSER INC
10-Q, EX-27, 2000-08-14
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Previous: HAUSER INC, 10-Q, 2000-08-14
Next: GREATER COMMUNITY BANCORP, 10-Q, 2000-08-14



<TABLE> <S> <C>

<ARTICLE>                                                           5
<CIK>                                                      0000773723
<NAME>                                                     HAUSER, INC.
<MULTIPLIER>                                                         1
<CURRENCY>                                                 U.S. DOLLARS

<S>                                      <C>
<PERIOD-TYPE>                            3-MOS
<FISCAL-YEAR-END>                                         MAR-31-2001
<PERIOD-START>                                             APR-1-2000
<PERIOD-END>                                              JUN-30-2000
<EXCHANGE-RATE>                                                     1
<CASH>                                                      1,082,267
<SECURITIES>                                                        0
<RECEIVABLES>                                              18,429,771
<ALLOWANCES>                                                 (782,228)
<INVENTORY>                                                20,037,995
<CURRENT-ASSETS>                                           39,900,685
<PP&E>                                                     37,630,494
<DEPRECIATION>                                            (23,568,609)
<TOTAL-ASSETS>                                             72,807,601
<CURRENT-LIABILITIES>                                      36,630,801
<BONDS>                                                             0
                                               0
                                                         0
<COMMON>                                                        4,820
<OTHER-SE>                                                 35,906,870
<TOTAL-LIABILITY-AND-EQUITY>                               72,807,601
<SALES>                                                    21,739,639
<TOTAL-REVENUES>                                           21,739,639
<CGS>                                                      19,511,518
<TOTAL-COSTS>                                              19,511,518
<OTHER-EXPENSES>                                            3,581,711
<LOSS-PROVISION>                                                    0
<INTEREST-EXPENSE>                                            570,297
<INCOME-PRETAX>                                            (1,923,887)
<INCOME-TAX>                                                        0
<INCOME-CONTINUING>                                        (1,923,887)
<DISCONTINUED>                                                      0
<EXTRAORDINARY>                                                     0
<CHANGES>                                                           0
<NET-INCOME>                                               (1,923,887)
<EPS-BASIC>                                                     (0.40)
<EPS-DILUTED>                                                   (0.40)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission